Document is current
Any future updates will be listed below
-
Authors
Liu, Guiming https://orcid.org/0000-0002-9292-6198
Elsayed, Ahmed Adham R. https://orcid.org/0000-0002-1227-4426
Kwantwi, Louis Boafo https://orcid.org/0000-0002-4015-2127
Gallardo-Macias, Ricardo https://orcid.org/0009-0008-1486-8261
Gurvich, Vadim J. https://orcid.org/0000-0002-5420-1639
Basson, Marc D. https://orcid.org/0000-0001-9696-2789
-
Funding
Funding for this research was provided by:
National Institutes of Health’s National Center for Advancing Translational Sciences (UL1TR002494)
National Institutes of Health (U01HL152410)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 24 April 2025
First Online: 8 May 2025
Declarations
:
: All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee (IACUC) of Northeast Ohio Medical University, with IACUC number 23-04-366. The experiments were conducted in accordance with relevant guidelines and regulations.
: Not applicable.
: The University of North Dakota and the University of Minnesota have filed two patent applications on the use of small-molecule FAK activators to promote mucosal healing. MDB and VJG are listed as co-inventors, and one also includes RGM.
